Synovel Sciences

Synovel Sciences is a research-driven biotechnology company focused on the discovery and development of novel small molecule therapeutics for unmet medical needs in oncology, inflammation, and central nervous system (CNS) disorders. Leveraging its proprietary drug discovery platform, the company specializes in scaffold-based design to identify high-quality lead compounds with optimized pharmacological profiles. Synovel's pipeline includes several early-stage programs targeting key biological pathways involved in disease progression. The company operates primarily out of its research facilities in Hyderabad, India, and collaborates with global partners to advance its candidates toward clinical development. Their expertise spans medicinal chemistry, in vitro biology, and ADME/PK, providing an integrated approach to drug discovery.